GB Sciences, Inc. (OTCMKTS:GBLX) Logo

The stock of GB SCIENCES INC (OTCMKTS:GBLX) registered a decrease of 64.96% in short interest. GBLX’s total short interest was 8,900 shares in August as published by FINRA. Its down 64.96% from 25,400 shares, reported previously.

The stock decreased 7.95% or $0.008 during the last trading session, reaching $0.0921. About 920,624 shares traded or 66.94% up from the average. GB Sciences, Inc. (OTCMKTS:GBLX) has 0.00% since August 16, 2018 and is . It has by 0.00% the S&P500.

GB Sciences, Inc., through its subsidiaries, focuses on the development of cannabis plant into medicines, therapies, and treatments for various ailments. The company has market cap of $22.67 million. The firm intends to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies through various technologies in plant biology, cultivation, and extraction techniques combined with biotechnology. It currently has negative earnings. It also focuses on the manufacture, production, leasing, and licensing of GrowBLOX, a controlled-climate indoor agricultural technology growing and cultivation chamber to produce medical grade cannabis and other plant extracts, as well as providing remote diagnostic monitoring and servicing of growing chambers to third party growers and processors of hemp, cannabis, and other plant extracts.

More notable recent GB Sciences, Inc. (OTCMKTS:GBLX) news were published by: which released: “Largest U.S. cannabis company listed on Canadian exchange – Seeking Alpha” on May 29, 2018, also with their article: “GB Sciences files patent application for the treatment of neuropathic pain using myrcene-based nanoparticles – Seeking Alpha” published on November 20, 2018, published: “GB Sciences Louisiana’s cannabis operations now open at LSU agricultural center – Seeking Alpha” on April 16, 2019. More interesting news about GB Sciences, Inc. (OTCMKTS:GBLX) were released by: and their article: “ potcasts – cannabis news and stocks to watch plus insight from thought leaders and experts –” published on August 30, 2018 as well as‘s news article titled: “GB Sciences launches GBS Global in Canada – Seeking Alpha” with publication date: March 19, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.